Literature DB >> 6507101

Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the inter-relationships between clinical and morphologic variables.

A Rydholm, N O Berg, B Gullberg, K G Thorngren, B M Persson.   

Abstract

From all soft-tissue malignancies reported to the Swedish National Cancer Registry in Southern Sweden (1.3 mill. inhabitants) from 1964 through 1978, 278 cases were accepted as sarcomas after histologic re-examination. All these were malignancy-graded on a four-grade scale, without knowledge of the clinical course. A number of clinical and morphological variables were recorded and subjected to uni-, bi- and multi-variate analysis. Follow-up was available in all patients. The annual incidence rate over all ages was 1.4/100,000. The mean age was 58 years and males dominated (1.3/1). Malignant fibrous histiocytoma, liposarcoma and leiomyosarcoma were the most common histologic groups. Three-fourths of the tumors were high-grade malignant (Grade III-IV). Sixty per cent were deep-seated, having a median size of 8 cm compared to 4 cm for the superficial tumors. One third of all tumors were located in the thigh. The histologic groups were characterized by age, tumor depth and size, the occurrence of pain, malignancy grade and five-year survival; it was seen that each group, with respect to at least one of the variables, differed significantly from all the other groups. Thus histologic classification seems to identify different tumor entities. Out of several pair-wise associations the strongest were as follows: histologic groups versus depth, size, malignancy grade and age; depth versus size; and size versus malignancy grade (Grade IV tumors being larger). The proportion of superficial and small tumors in this series is high, compared to several reported series, probably owing to "referral selection" in the previous studies. The inter-relationships found between several variables and conclusions based on selected series may explain, in part, the differing opinions which can be found in the literature regarding prognostic variables in soft-tissue sarcoma.

Entities:  

Mesh:

Year:  1984        PMID: 6507101

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand A        ISSN: 0108-0164


  8 in total

1.  Epithelioid malignant schwannoma. A study of 14 cases.

Authors:  P Lodding; L G Kindblom; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Diagnosis and planning in the management of musculoskeletal tumors: surgical perspective.

Authors:  Onder Ofluoglu; Stefano Boriani; Alessandro Gasbarrini; Federico De Iure; Rakesh Donthineni
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

Review 3.  Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours.

Authors:  J F Graadt van Roggen; J V Bovée; J Morreau; P C Hogendoorn
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

4.  Malignant fibrous histiocytoma of rectum: Report of a case.

Authors:  Rasoul Azizi; Bahar Mahjoubi; Nasrin Shayanfar; Fakhryalsadat Anaraki; Leila Zahedi-Shoolami
Journal:  Int J Surg Case Rep       Date:  2011-04-04

5.  Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.

Authors:  Sameer Yaser; Samer Salah; Marwa Al-Shatti; Areej Abu-Sheikha; Ahmad Shehadeh; Iyad Sultan; Ahmad Salem; Maher Sughayer; Shaymaa Al-Loh; Abdelatif Al-Mousa
Journal:  Med Oncol       Date:  2014-04-26       Impact factor: 3.064

6.  Preoperative diagnosis of soft tissue tumours.

Authors:  A Rydholm; T Alvegård; N O Berg; Z Dawiskiba; N Egund; I Idvall; H Pettersson; B Rööser; H Willén; M Akerman
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075

7.  [Soft tissue sarcoma].

Authors:  P-U Tunn; B Gebauer; J Fritzmann; M Hünerbein; P M Schlag
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

8.  [Neoadjuvant radiochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control].

Authors:  R Sauer; U Schuchardt; W Hohenberger; C Wittekind; T Papadopoulos; G G Grabenbauer; R Fietkau
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.